The main reason for the improvements in facing leukaemia is "the development of new treatments, combined with good levels of recruitment to UK clinical trials", according to the research's lead author.
Dr Anjali Shah, from the London School of Hygiene & Tropical Medicine and the University of Oxford, added:
These key issues have been effective in curing more people of acute myeloid leukaemia (AML).
But levels of cure of this disease in England remain lower than those observed in other European countries, such as Sweden.
The reasons for these differences are unknown.
More top news
Figures released by Network Rail and the Samaritans show there have been 33 more deaths on the tracks in the last year.
NHS trusts are denying thousands of women across Britain fertility treatment in a bid to cut costs, a health watchdog has warned.
Overhaul of NHS would include workplace weight-loss schemes with money and shopping voucher prizes.